Tagged with Lonza

Switzerland: Pharma Reacts Cautiously to India Free Trade Deal; Novartis Acquires MorphoSys
Top Biologics CDMOs 2023
5 Leading European CDMOs 2023
Top Global CDMOs 2022
Jennifer Cannon, SVP Global Head Mammalian Biologics – Lonza
PharmaBoardroom’s 10 Most Read Interviews of 2021
Jean-Christophe Hyvert – President Biologics and Cell & Gene, Lonza
China News Roundup: Sinopharm Looks to mRNA Vaccines; Hong Kong Biotech Investment Continues to Boom; Another Big Manufacturing Investment for Lonza
China Pharma News: First CAR-T Approval; AZ & Bayer Take VBP Hit; Lonza Boosts Manufacturing Capacity
Lonza Goes Big with Swiss Investments in Biologics, ADCs & Vaccines Manufacturing
Top 5 Global CDMOs
Outsourced Manufacturing: A Swiss Specialty
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here